SYNGENE INTERNATIO
SYNGENE.NS
₹ 752.50
1%

Syngene International Ltd

Syngene International Ltd is a Small Cap stock that belongs to the Miscellaneous sector. The current live share price of Syngene is ₹ 752.50 that is ₹ 7.95 1.07% with respect to the previous day’s close price. The stock price of Syngene was last updated 1 day ago.

Syngene Stock Price Performance

In the below section, we have evaluated the stock’s price performance for the last traded day as well as historical time frames.

Syngene Live Share Price Analysis

SYNGENE INTERNATIO
₹ 752.50
Open ₹ 743.60
High ₹ 753.50
Marketcap 301.97B
Close ₹ 752.50
Low ₹ 742.50
Volume ₹ 623,458.00

The stock of Syngene International Ltd strated the trade at an Open price of ₹ 743.60 when the trading at exchange began for the day. It touched an Intraday High price of ₹ 753.50 and an Intraday Low price of ₹ 742.50%. As per last updated 1 day ago, the Shares of Syngene were trading at a price of ₹ 752.50 which is ₹ 7.95 1.07% as compared the price ₹ 744.55 at which the stock close on the previous trading day. The total traded volume for the day stood at 623,458 number of shares.

Candlestick Chart of Syngene Share Price Movements

The following candlestick Chart of the Stock shows how the Open, High, Low, Close (OHLC) Price of the share has performed in the last month (30-day period).

Historical Performance of Syngene Shares

52 Week RangePrice52 Weeks Low52 Weeks High
₹ 752.50₹ 607.65₹ 860.25

Here is Syngene’s price performance analysis over the last year. The stock has seen the 52 weeks high price level of ₹ 860.25. On the lower side, the stock has been to the 52 weeks low price level of ₹ 607.65. It’s last traded price was ₹ 752.50 as on last update 1 day ago. The one-year line chart clearly shows how the price of Syngene’s stock has moved in the last twelve months.

The Company has posted an earnings of ₹ 12.71 per share (EPS TTM) in the trailing twelve months period. Syngene’s last annual dividend rate was 1.25%, which translates to a 0.17% of annual dividend yield.

Line Chart of Syngene Stock Price

Here is the chart of stock price performance for the last one year. You can also view the price performance of a different period by selecting the time frame from the top right corner.

Companies Similar to Syngene

Syngene International Ltd belongs to the Miscellaneous sector. It has several competitors in the same industry. The snapshot of the live share price of some of the companies similar to Syngene are listed below. You can click and view the details of stock analysis, current and historical share price, company background information about each company.

Share Price Snapshot Companies Similar to Syngene

Select list of companies is given below. To view more about the Industry and see other companies from Industry, click on the industry name.
AARVI.NSAarvi Encon Limited
₹ 132.00
NSE
₹ 0.13
0.10%
AJOONI.NSAjooni Biotech Limited
₹ 6.65
NSE
₹ 0.13
1.92%
AWHCL.NSAntony Waste Hdg Cell Ltd
₹ 625.00
NSE
₹ 22.10
3.67%
ARROWGREEN.NSARROW GREENTECH LI
₹ 566.00
NSE
₹ 5.10
0.91%
BLS.NSBLS INTERNATIONAL
₹ 363.90
NSE
₹ 1.60
0.44%
BOMBCYC.BOBOMBAY CYCLE & MOTOR AGENCY LT
₹ 1,921.45
BSE
₹ 43.70
2.22%
CHARMS.BOCHARMS INDUSTRIES LTD.
₹ 7.10
BSE
₹ 0.0000
0.00%
CITYONLINE.BOCity Online Services Limited
₹ 6.47
BSE
₹ 0.0000
0.00%
DELTACORP.NSDELTA CORP LTD
₹ 143.50
NSE
₹ 1.49
1.05%

About Syngene

Syngene International Ltd is a Private Company. The company operates in the Miscellaneous sector. It is a contract research company. Incorporated in 1993, it has around 28 years of operations. Syngene live share price is ₹ 752.50. It is a Small Cap stock and had a market capitalization of ₹ 301,972,979,712.00 as on 1 day ago.

  • Syngene is engaged in providing contract research and manufacturing services in early-stage drug discovery and development to pharmaceutical and biotechnology companies.
  • Its services include discovery chemistry and biology services, toxicology, pharmaceutical development, process development/manufacture of intermediates, active pharmaceutical ingredients and bio-therapeutics.
  • Its services encompass integrated, discovery and development services for novel molecular entities (NMEs) across industrial sectors, including pharmaceutical, biopharmaceutical and biotechnology, among others.
  • It specializes in conducting discovery (from hit to candidate selection), development (including pre-clinical and clinical studies, analytical and bio-analytical evaluation, and stability studies) and manufacturing (scale-up, pre-clinical and manufacturing supplies).
  • It serves clients ranging from multinational corporations to start-ups.

The registered office of Syngene is located in Bengaluru, Karnataka. The registrar and share transfer agent for Syngene is K FIN Technologies Pvt Ltd. The Stock Exchanges on which shares of Syngene International Ltd is listed includes BSE, NSE.

SYNGENE INTERNATIO
Status: Active
Sector: Healthcare
Industry: Biotechnology
Employees: 6510
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals; and chemical, formulation, analytical, and clinical development services, as well as commercial manufacturing and sterile fill-finish services. It also provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical studies, biometrics and clinical data management, central lab, regulatory, medical monitoring, pharmacovigilance, and medical writing services. In addition, the company offers chemistry, biology, safety assessment, computational, and data sciences for traditional small molecule therapeutics; biologics; and specialty modalities, such as peptides, oligonucleotides, antibody-drug conjugates, and targeted degradation/stabilization. It serves pharmaceutical, biotechnology, animal health, nutrition, consumer goods, agrochemical, performance and specialty materials, and other companies. The company has collaborations with Bristol-Myers Squibb, Baxter Inc., and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.
AddressVelankani Technology Park, Bengaluru, India
CountryIndia
Phone91 80 6891 9191
Websitehttps://www.syngeneintl.com

Syngene Recent News

No Recent News found for Syngene International Ltd.